Marpel Inc - New York City, New York 10001

Marpel Inc is categorized under in New York City, NY .

Business Name: Marpel Inc
Contact Person: Paul Lieberman
Address: 306 8th Avenue, New York City, New York 10001
Phone Number: (212) 255-9111
Annual Revenue (USD): $500.000 to $999.999
Founding Year: 1982
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category:
SIC Code: 5912
NAICS Code: 446110
Share This Business:
Related Businesses: Drug Trails Florida Inc - New York City, NY 10001
Duane Reade - New York City, NY 10001
Harris & Klein - New York City, NY 10001
Promesa Drug Rehabilitation Cn - New York City, NY 10001
Duane Reade - New York City, NY 10001
Central Fill Pharmacy Inc - New York City, NY 10001
Infu Rx - New York City, NY 10001
Rexall Showcase Master Independent Distribution - New York City, NY 10001
Us Medicine Care - New York City, NY 10001
Top Drug Mart24 - New York City, NY 10001
Duane Reade - New York City, NY 10001
Rapheal Drug & Health Ltd - New York City, NY 10001
Drug Policy Action - New York City, NY 10001
Ahf Pharmacy - New York City, NY 10001
Duane Reade - New York City, NY 10001
Duane Reade - New York City, NY 10001
Cici Pharmacy Inc - New York City, NY 10001
Eureka - New York City, NY 10001
Duane Reade - New York City, NY 10001
Duane Reade - New York City, NY 10001

The company Marpel Inc provides B2C services in the form of from its single location in New York. 1 to 4 employees work for Marpel Inc, and the business now earns $500.000 to $999.999 per annum.

Marpel Inc was launched in 1982 and is classified under SIC code and category 5912 , and NAICS number and grouping 446110 . To contact Marpel Inc, please call Paul Lieberman with the phone number (212) 255-9111 or visit its single location at 306 8th Avenue in New York City, New York 10001.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.